Update in the Reversal of Oral Anticoagulants: New Developments and Clinical Strategies
Jointly provided by Postgraduate Institute for Medicine and CMEology.
This activity is supported by an independent education grant from Baxalta US Inc.
Scroll to the Bottom of this Information to Begin this Course
Release date: October 2015
Valid through: October 2016
Estimated Time to Complete Activity: 1.25 hours
This activity has been designed to meet the educational needs of healthcare providers, including physicians and registered nurses, who manage patients undergoing treatment with anticoagulant therapies.
Upon completion of this activity, participants should be better able to:
- Apply strategies for reversal of vitamin K antagonist anticoagulants
- Apply strategies for reversal of direct thrombin inhibitors and factor Xa inhibitors
- Differentiate among the prothrombin complex concentrates and their use in anticoagulant reversal
- Provide appropriate care and counsel for patients and their families
- Physicians — maximum of 1.25 AMA PRA Category 1 Credits™
- Nurses — 1.1 contact hours
All other healthcare professionals completing this course will be issued a statement of participation.
Sam Schulman, MD, PhD, FRCPC(C) – Chairperson
Professor, Department of Medicine
Director, Clinical Thromboembolism Program
Hamilton Health Sciences - General Hospital
Hamilton, Ontario, Canada
Associate Professor, Medicine
Marcel Levi, MD, PhD
Professor of Medicine
Dean, Faculty of Medicine
University of Amsterdam
Chairman, Department of Medicine
Academic Medical Center of the University of Amsterdam
Amsterdam, the Netherlands
Yulia Lin, MD, FRCPC
Transfusion Medicine & Hematology
Sunnybrook Health Sciences
Department of Laboratory Medicine and Pathobiology
University of Toronto
Toronto, Ontario, Canada
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and CMEology. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
This educational activity for 1.1 contact hours is provided by Postgraduate Institute for Medicine.
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Disclosures of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
- No financial relationships to report.
- Consulting Fees (e.g., advisory boards): Genzyme Corporation, Boehringer Ingelheim
- Contracted Research: GlaxoSmithKline
- Consulting Fees (e.g., advisory boards): Boehringer Ingelheim, Bayer AG, Bristol-Myers Squibb Company
- Contracted Research: Boehringer Ingelheim, Octapharma AG, Baxter Healthcare Corporation
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, MSN, RN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
The following CMEology planners and managers, Rob Lowney, Dana Ravyn, PhD, MPH, and Rachael Soranno hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this activity. During the period October 2015 through October 2016, participants must read the learning objectives and faculty disclosures and study the educational activity. . If you pass the post-test and complete the evaluation, your certificate will be available immediately for download in PDF format.
Hardware and Software Requirements
This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.